Evaluation of static and dynamic MRI for assessing response of bone sarcomas to preoperative chemotherapy: Correlation with histological necrosis
- PMID: 26288521
- PMCID: PMC4531451
- DOI: 10.4103/0971-3026.161452
Evaluation of static and dynamic MRI for assessing response of bone sarcomas to preoperative chemotherapy: Correlation with histological necrosis
Abstract
Objectives: Preoperative chemotherapy plays a key role in management of bone sarcomas. Postoperative evaluation of histological necrosis has been the gold standard method of assessing response to preoperative chemotherapy. This study was done to evaluate the efficacy of static and dynamic magnetic resonance imaging (MRI) for assessing response preoperatively.
Materials and methods: Our study included 14 patients (12 osteosarcomas and 2 malignant fibrous histiocytomas) with mean age of 21.8 years, treated with preoperative chemotherapy followed by surgery. They were evaluated with static and dynamic MRI twice, before starting chemotherapy and again prior to surgery. Change in tumor volume and slope of signal intensity - time curve were calculated and correlated with percentage of histological necrosis using Pearson correlation test.
Results: The change in dynamic MRI slope was significant (P = 0.001). Also, ≥60% reduction in slope of the curve proved to be an indicator of good histological response [positive predictive value (PPV) =80%]. Change in tumor volume failed to show significant correlation (P = 0.071). Although it showed high negative predictive value (NPV = 85.7%), PPV was too low (PPV = 57.14%).
Conclusions: Dynamic MRI correctly predicts histological necrosis after administration of preoperative chemotherapy to bone sarcomas. Hence, it can be used as a preoperative indicator of response to neoadjuvant chemotherapy. On the other hand, volumetric assessment by static MRI is not an effective predictor of histological necrosis. This study proves the superiority of dynamic contrast-enhanced study over volumetric study by MRI.
Keywords: Dynamic MR; MR; histological necrosis; malignant fibrous histiocytoma; osteosarcoma; preoperative chemotherapy.
Conflict of interest statement
Figures






Similar articles
-
Role of dynamic MRI and clinical assessment in predicting histologic response to neoadjuvant chemotherapy in bone sarcomas.Am J Clin Oncol. 2014 Aug;37(4):384-90. doi: 10.1097/COC.0b013e31827b4f6f. Am J Clin Oncol. 2014. PMID: 23388556 Clinical Trial.
-
MRI for evaluation of preoperative chemotherapy in osteosarcoma.Radiography (Lond). 2022 Aug;28(3):593-604. doi: 10.1016/j.radi.2022.04.008. Epub 2022 May 7. Radiography (Lond). 2022. PMID: 35537246
-
Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.Invest Radiol. 2006 Aug;41(8):618-23. doi: 10.1097/01.rli.0000225398.17315.68. Invest Radiol. 2006. PMID: 16829744
-
Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.Pediatr Radiol. 2004 Aug;34(8):595-605. doi: 10.1007/s00247-004-1192-x. Epub 2004 Apr 22. Pediatr Radiol. 2004. PMID: 15103428 Review.
-
Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.Medicine (Baltimore). 2018 Dec;97(51):e13308. doi: 10.1097/MD.0000000000013308. Medicine (Baltimore). 2018. PMID: 30572434 Free PMC article.
Cited by
-
Indian data on bone and soft tissue sarcomas: A summary of published study results.South Asian J Cancer. 2016 Jul-Sep;5(3):138-45. doi: 10.4103/2278-330X.187587. South Asian J Cancer. 2016. PMID: 27606300 Free PMC article. Review.
-
Diagnostic work up and recognition of primary bone tumours: a review.EFORT Open Rev. 2017 Mar 13;1(6):247-253. doi: 10.1302/2058-5241.1.000035. eCollection 2016 Jun. EFORT Open Rev. 2017. PMID: 28461955 Free PMC article. Review.
-
A Scoring System for Predicting Neoadjuvant Chemotherapy Response in Primary High-Grade Bone Sarcomas: A Multicenter Study.Orthop Surg. 2022 Oct;14(10):2499-2509. doi: 10.1111/os.13469. Epub 2022 Aug 26. Orthop Surg. 2022. PMID: 36017768 Free PMC article.
-
Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.Br J Radiol. 2020 Nov 1;93(1115):20200257. doi: 10.1259/bjr.20200257. Epub 2020 Oct 15. Br J Radiol. 2020. PMID: 32706980 Free PMC article.
-
Correlation of histopathology and multi-modal magnetic resonance imaging in childhood osteosarcoma: Predicting tumor response to chemotherapy.PLoS One. 2022 Feb 14;17(2):e0259564. doi: 10.1371/journal.pone.0259564. eCollection 2022. PLoS One. 2022. PMID: 35157711 Free PMC article.
References
-
- Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience. Cancer. 1992;69:698–708. - PubMed
-
- Wunder JS, Paulian G, Huvos AG, Heller G, Meyers PA, Healey JH. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998;80:1020–33. - PubMed
-
- Kawai A, Sugihara S, Kunisada T, Uchida Y, Inoue H. Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop Relat Res. 1997;337:216–25. - PubMed
-
- Raymond AK, Chawla SP, Carrasco CH, Ayala AG, Fanning CV, Grice B, et al. Osteosarcoma chemotherapy effect: A prognostic factor. Semin Diagn Pathol. 1987;4:212–36. - PubMed
-
- Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221–30. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources